Prevalence of Restless Legs Syndrome Among Psychiatric Patients Who are Under Antidepressant or Antipsychotic Monotherapy

Semiz M., Solmaz V., AKSOY D., Inanir S., ÇOLAK B., Gokbakan M. A., ...More

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, vol.26, no.2, pp.161-168, 2016 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.5455/bcp.20150908024954
  • Journal Name: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.161-168
  • Keywords: antidepressant, antipsychotic, restless legs syndrome, adverse effect, PERIODIC LIMB MOVEMENTS, RATING-SCALE, QUETIAPINE, DEPRESSION, MIRTAZAPINE, SCHIZOPHRENIA, SLEEP, ASSOCIATION, ROPINIROLE, OLANZAPINE
  • Ankara University Affiliated: No

Abstract

Objective: Several groups of medications, such as dopamine blockers, analgesics and antihistaminergics were associated with restless legs syndrome (RLS). Although case reports showed some significant relations, they have many methodological limitations such as co-medications or medical co-morbidities. The aim of this study was to investigate the prevalence and severity of RLS in patients on antidepressant (AD) or antipsychotic (AP) monotherapy.